Sahil Agrawal

Sahil Agrawal

Auto-generated profile, based on publicly available information

Sahil Agrawal

Department of Cardiology, St. Luke's University Health Network, Bethlehem, Pennsylvania

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Circulation: Heart Failure
Verified
Journal Article
Closed access
PDF file
SASahil Agrawal
Sahil Agrawal
LGLohit Garg
Lohit Garg
MSMahek Shah
Mahek Shah
MAManyoo Agarwal
Manyoo Agarwal
BPBrijesh Patel
Brijesh Patel
NKNavin K. Kapur
Navin K. Kapur
Background: Early readmissions contribute significantly to heart failure–related morbidity and negatively affect quality of life. Data on left ventricular assist device (LVAD)–related 30-day readmissions are scarce and limited to small studies. Methods and Results: Patients undergoing LVAD implantation between January 2013 and November 2014 who survived the index hospitalization were identified in the Nationwide Readmissions Database. We analyzed the incidence, predictors, causes, and costs of 30-day readmissions. Of 2510 LVAD recipients, 788 (31%) were readmitted within 30 days. Length of index hospitalization ≥31 days (hazard ratio [HR], 1.26; 95% confidence interval [CI], 1.07–1.50) and female sex (HR, 1.19; 95% CI, 1.01–1.42) were associated with a higher risk of 30-day readmission, whereas private insurance (HR, 0.83; 95% CI, 0.70–0.99), pre-LVAD use of short-term mechanical circulatory support (HR, 0.53; 95% CI, 0.29–0.98), and discharge to a short-term hospital facility (HR, 0.41; CI, 0.21–0.78) were associated with a lower risk. Cardiac causes accounted for 23.8% of readmissions: heart failure (13.4%) and arrhythmias (8.1%). Noncardiovascular causes accounted for 76.2% of readmissions: infection (30.2%), bleeding (17.6%), and device-related causes (8.2%). Mean length of stay for readmission was 10.7 days (median, 6 days), and average hospital cost per readmission was $34 948±2457. Conclusions: Early readmissions are frequent after LVAD implantation even in contemporary times. Preimplant identification of high-risk patients, and a protocol-driven follow-up using a multidisciplinary approach will be needed to reduce readmissions and improve outcomes.

16 March 2017 in Clinical Cardiology
Verified
Journal Article
Closed access
PDF file
NBNirmanmoh Bhatia
Nirmanmoh Bhatia
SASahil Agrawal
Sahil Agrawal
AGAakash Garg
Aakash Garg
DMDivyanshu Mohananey
Divyanshu Mohananey
ASAbhishek Sharma
Abhishek Sharma
JSJamshid Shirani
Jamshid Shirani

1 November 2016 in International Journal of Cardiology
Verified
Journal Article
Closed access
SASahil Agrawal
Sahil Agrawal
LGLohit Garg
Lohit Garg
SNSudip Nanda
Sudip Nanda
ASAbhishek Sharma
Abhishek Sharma
NBNirmanmoh Bhatia
Nirmanmoh Bhatia
JSJamshid Shirani
Jamshid Shirani

30 May 2017 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
ASAbhishek Sharma
Abhishek Sharma
SASahil Agrawal
Sahil Agrawal
AGAakash Garg
Aakash Garg
AVAjay Vallakati
Ajay Vallakati
CLCarl J. Lavie
Carl J. Lavie
GHGerald Helft
Gerald Helft

1 September 2016 in The American Journal of Cardiology
Verified
Journal Article
Closed access
SASahil Agrawal
Sahil Agrawal
LGLohit Garg
Lohit Garg
ASAbhishek Sharma
Abhishek Sharma
DMDivyanshu Mohananey
Divyanshu Mohananey
NBNirmanmoh Bhatia
Nirmanmoh Bhatia
SDSimon Dixon
Simon Dixon

1 January 2017 in World Journal of Cardiology
Verified
Journal Article
Open access
SASahil Agrawal
Sahil Agrawal
JSJamshid Shirani
Jamshid Shirani
LGLohit Garg
Lohit Garg
ASAmitoj Singh
Amitoj Singh
SLSanto Longo
Santo Longo
SNSudip Nanda
Sudip Nanda
To investigate the occurrence of cardiomyopathy (CMP) in a cohort of patients with histologically proven pheochromocytoma (pheo), and to determine if catecholamine excess was causative of the left ventricular (LV) dysfunction. A retrospective chart review spanning years 1998 through 2014 was undertaken and patients with a diagnosis of pheo confirmed with histopathologic examination were included. Presenting electrocardiograms and cardiac imaging studies were reviewed. Transthoracic echocardiography (TTE), ventriculography or single positron emission computed tomography imaging was evaluated and if significant abnormalities [left ventricular hypertrophy (LVH) or LV dysfunction] were noted in the pre operative period a follow up post-operative study was also analyzed. Multivariate analysis using logistic regression was used to investigate independent predictors for outcomes of interest, LV dysfunction and LVH. We identified 18 patients with diagnosis of pheo confirmed on pathology. Mean age was 54.3 ± 19.3 years and 11 (61.1%) patients were females. 50% of such patients had either resistant hypertension or labile blood pressures during hospitalization, which had raised suspicion for a pheo. Cardiac imaging studies were available for 12 (66.7%) patients at the time of inclusion into study and preceding the adrenalectomy. 7 (58.3%) patients with a TTE available for review had mild or more severe LVH while 3 (25%) patients had LV dysfunction of presumably acute onset. In a multivariate analysis, elevated catecholamine levels as assessed by urinary excretion of metabolites was not an independent predictor of development of LV systolic dysfunction or of presence of LVH on TTE. Two female patients with a preceding history of hypertension had marked LV hypertrophy and systolic anterior motion of the mitral valve. Prolongation of the QTc interval was noted in 5 (27.8%) patients but no acute arrhythmias were observed in any patient. This study adds to the growing body of literature on the predilection of patients with pheochromocytomas to develop non-ischemic CMP. Degree of catecholamine excess as measured by urinary secretion of metabolites did not predict the development of CMP but 2 of 3 patients developed CMP in the setting of significant acute physiologic stress. Our findings provide support to the proposed etiologic role of elevated catecholamines in TC and other stress induced forms of CMP, however, activation of a brain-neural-cardiac axis from acute stress and local release of catecholamines but not chronic catecholamine elevations are likely to be responsible in pheo related CMP.